Moreover, we previously found that the T cell‐derived cytokines IL‐21 and IL‐4 differentially affect Bcl‐XL expression and sensitivity to venetoclax in vitro and that both are abundantly expressed in the CLL microenvironment [12, 16, 17, 18]. This evidence concerns the gene IL21 and B-cell chronic lymphocytic leukemia.